|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-5-24
|
|
pubmed:abstractText |
To report efficacy and safety of transitioning patients receiving intramuscular (IM) formulations of aripiprazole or haloperidol to their respective oral formulations.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1527-4160
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
170-7
|
|
pubmed:meshHeading |
pubmed-meshheading:17522560-Acute Disease,
pubmed-meshheading:17522560-Administration, Oral,
pubmed-meshheading:17522560-Adolescent,
pubmed-meshheading:17522560-Adult,
pubmed-meshheading:17522560-Aged,
pubmed-meshheading:17522560-Antipsychotic Agents,
pubmed-meshheading:17522560-Double-Blind Method,
pubmed-meshheading:17522560-Dyskinesia, Drug-Induced,
pubmed-meshheading:17522560-Female,
pubmed-meshheading:17522560-Haloperidol,
pubmed-meshheading:17522560-Humans,
pubmed-meshheading:17522560-Injections, Intramuscular,
pubmed-meshheading:17522560-Male,
pubmed-meshheading:17522560-Middle Aged,
pubmed-meshheading:17522560-Piperazines,
pubmed-meshheading:17522560-Psychiatric Status Rating Scales,
pubmed-meshheading:17522560-Psychomotor Agitation,
pubmed-meshheading:17522560-Psychotic Disorders,
pubmed-meshheading:17522560-Quinolones,
pubmed-meshheading:17522560-Schizophrenia
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations.
|
|
pubmed:affiliation |
United BioSource Corporation, McLean, VA 22106, USA. ddanielmd@cox.net
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|
